Skip Nav Destination
Issues
February 2003
EISSN 1660-2110
In this Issue
Nephron Clinical Practice 2003, Vol. 93, No. 2
Comment & Analysis
Treating IgA Nephropathy – Who, When and How?: See Goumenos et al., pp c58–68
Subject Area:
Nephrology
Nephron Clinical Practice (2003) 93 (2): c47–c48.
https://doi.org/10.1159/000068523
Another Marker of Cardiac Dysfunction in Dialysis Patients?: See Furuhashi et al., pp. c69–c74
Subject Area:
Nephrology
Nephron Clinical Practice (2003) 93 (2): c49–c50.
https://doi.org/10.1159/000068525
Minireview
The Importance of Associated Extra-Renal Vascular Disease on the Outcome of Patients with Atherosclerotic Renovascular Disease
Subject Area:
Nephrology
Nephron Clinical Practice (2003) 93 (2): c51–c57.
https://doi.org/10.1159/000068521
Original Paper
Prednisolone and Azathioprine in IgA Nephropathy: A Ten-Year Follow-Up Study
Subject Area:
Nephrology
Dimitrios S. Goumenos; Periklis Davlouros; A. Meguid El Nahas; Manohar Ahuja; John R. Shortland; John G. Vlachojannis; Colin B. Brown
Nephron Clinical Practice (2003) 93 (2): c58–c68.
https://doi.org/10.1159/000068522
Serum Ratio of Heart-Type Fatty Acid-Binding Protein to Myoglobin: A Novel Marker of Cardiac Damage and Volume Overload in Hemodialysis Patients
Subject Area:
Nephrology
Masato Furuhashi; Nobuyuki Ura; Koichi Hasegawa; Hideaki Yoshida; Kazufumi Tsuchihashi; Tomoaki Nakata; Kazuaki Shimamoto
Nephron Clinical Practice (2003) 93 (2): c69–c74.
https://doi.org/10.1159/000068520
One-Year Growth Hormone Therapy Improves Granulocyte Function without Major Effects on Nutritional and Anthropometric Parameters in Malnourished Hemodialysis Patients
Subject Area:
Nephrology
Harald Kotzmann; Alice Schmidt; Piero Lercher; Ernst Schuster; Georg Geyer; Herwig Frisch; Walter H. Hörl; Gert Mayer; Anton Luger
Nephron Clinical Practice (2003) 93 (2): c75–c82.
https://doi.org/10.1159/000068524
Further Section
Corrigendum
Subject Area:
Nephrology
Nephron Clinical Practice (2003) 93 (2): c82.
https://doi.org/10.1159/000069770
